Can Saccharomyces cerevisiae keep up as a model system in fungal azole susceptibility research?

The difficulty of manipulation and limited availability of genetic tools for use in many pathogenic fungi hamper fast and adequate investigation of cellular metabolism and consequent possibilities for antifungal therapies. S. cerevisiae is a model organism that is used to study many eukaryotic systems. In this review, we analyse the potency and relevance of this model system in investigating fungal susceptibility to azole drugs. Although many of the concepts apply to multiple pathogenic fungi, for the sake of simplicity, we will focus on the validity of using S. cerevisiae as a model organism for two Candida species, C. albicans and C. glabrata. Apart from the general benefits, we explore how S. cerevisiae can specifically be used to improve our knowledge on azole drug resistance and enables fast and efficient screening for novel drug targets in combinatorial therapy. We consider the shortcomings of the model system, yet conclude that it is still opportune to use S. cerevisiae as a model system for pathogenic fungi in this era.

• Publication year

  2019

• Venue

  Drug resistance updates

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.drup.2019.02.002PMID 30822675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TOR complex 2–regulated protein kinase Ypk1 controls sterol distribution by inhibiting StARkin domain–containing proteins located at plasma membrane–endoplasmic reticulum contact sites

  2018cited by this paper
• Altered sterol metabolism in budding yeast affects mitochondrial iron–sulfur (Fe-S) cluster synthesis

  2018cited by this paper
• Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs

  2018cited by this paper
• Crystal Structures of Full-Length Lanosterol 14α-Demethylases of Prominent Fungal Pathogens Candida albicans and Candida glabrata Provide Tools for Antifungal Discovery

  2018cited by this paper
• A Genome-Wide Screen of Deletion Mutants in the Filamentous Saccharomyces cerevisiae Background Identifies Ergosterol as a Direct Trigger of Macrophage Pyroptosis

  2018cited by this paper
• Generating genomic platforms to study Candida albicans pathogenesis

  2018cited by this paper
• Overexpression or Deletion of Ergosterol Biosynthesis Genes Alters Doubling Time, Response to Stress Agents, and Drug Susceptibility in Saccharomyces cerevisiae

  2018cited by this paper
• Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia

  2018cited by this paper
• Metabolomic profiling for the identification of potential biomarkers involved in a laboratory azole resistance in Candida albicans

  2018cited by this paper
• Oxysterol-binding protein homologs mediate sterol transport from the endoplasmic reticulum to mitochondria in yeast

  2018cited by this paper
• Introducing fluorescence resonance energy transfer‐based biosensors for the analysis of cAMP‐PKA signalling in the fungal pathogen Candida glabrata

  2018cited by this paper
• Rate-limiting steps in the Saccharomyces cerevisiae ergosterol pathway: towards improved ergosta-5,7-dien-3β-ol accumulation by metabolic engineering

  2018cited by this paper
• Comparative genomic and transcriptomic analyses unveil novel features of azole resistance and adaptation to the human host in Candida glabrata

  2018cited by this paper
• Robust, pleiotropic drug resistance 5 (Pdr5)-mediated multidrug resistance is vigorously maintained in Saccharomyces cerevisiae cells during glucose and nitrogen limitation

  2018cited by this paper
• Recent Advances in Ergosterol Biosynthesis and Regulation Mechanisms in Saccharomyces cerevisiae

  2017cited by this paper
• Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species

  2017cited by this paper
• Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase

  2017cited by this paper
• Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species

  2017cited by this paper
• Role of Ectopic Gene Conversion in the Evolution of a Candida krusei Pleiotropic Drug Resistance Transporter Family

  2017cited by this paper
• A Bimolecular Fluorescence Complementation Tool for Identification of Protein-Protein Interactions in Candida albicans

  2017cited by this paper
• Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase

  2017cited by this paper
• Mitochondrial Cochaperone Mge1 Is Involved in Regulating Susceptibility to Fluconazole in Saccharomyces cerevisiae and Candida Species

  2017cited by this paper
• Towards the design of an optimal strategy for the production of ergosterol from Saccharomyces cerevisiae yeasts

  2017cited by this paper
• Fungal microbiota dysbiosis in IBD

  2016cited by this paper
• Candida albicans cell-type switching and functional plasticity in the mammalian host

  2016cited by this paper
• Genome engineering in the yeast pathogen Candida glabrata using the CRISPR-Cas9 system

  2016cited by this paper
• Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease

  2016cited by this paper
• New Horizons in Antifungal Therapy

  2016cited by this paper
• Targeted Genome Editing via CRISPR in the Pathogen Cryptococcus neoformans

  2016cited by this paper
• Transcriptional rewiring over evolutionary timescales changes quantitative and qualitative properties of gene expression

  2016cited by this paper
• The Candida Genome Database (CGD): incorporation of Assembly 22, systematic identifiers and visualization of high throughput sequencing data

  2016cited by this paper
• Mutations of charged amino acids at the cytoplasmic end of transmembrane helix 2 affect transport activity of the budding yeast multidrug resistance protein Pdr5p.

  2016cited by this paper
• Targeting efflux pumps to overcome antifungal drug resistance.

  2016cited by this paper
• The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn

  2016cited by this paper
• Mitochondrial Complex I Is a Global Regulator of Secondary Metabolism, Virulence and Azole Sensitivity in Fungi

  2016cited by this paper
• Rewiring of the Ppr1 Zinc Cluster Transcription Factor from Purine Catabolism to Pyrimidine Biogenesis in the Saccharomycetaceae.

  2016cited by this paper
• Effects of fluconazole on the metabolomic profile of Candida albicans.

  2016cited by this paper
• Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study

  2016cited by this paper
• Identification and characterization of Candida utilis multidrug efflux transporter CuCdr1p.

  2016cited by this paper
• Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals

  2016cited by this paper
• Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase

  2015cited by this paper
• Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance

  2015cited by this paper
• High-Copy Overexpression Screening Reveals PDR5 as the Main Doxorubicin Resistance Gene in Yeast

  2015cited by this paper
• Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms

  2015cited by this paper
• The multidrug transporter Pdr5 on the 25th anniversary of its discovery: an important model for the study of asymmetric ABC transporters.

  2015cited by this paper
• An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens.

  2015cited by this paper
• Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.

  2015cited by this paper
• A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families

  2015cited by this paper
• Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing

  2015cited by this paper
• High-Throughput Identification of Cis-Regulatory Rewiring Events in Yeast.

  2015cited by this paper
• Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.

  2015cited by this paper
• Development of the CRISPR/Cas9 System for Targeted Gene Disruption in Aspergillus fumigatus

  2015cited by this paper
• Changes in the Sterol Composition of the Plasma Membrane Affect Membrane Potential, Salt Tolerance and the Activity of Multidrug Resistance Pumps in Saccharomyces cerevisiae

  2015cited by this paper
• The Yeast Deletion Collection: A Decade of Functional Genomics

  2014cited by this paper
• Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer

  2014cited by this paper
• Systematic Phenotyping of a Large-Scale Candida glabrata Deletion Collection Reveals Novel Antifungal Tolerance Genes

  2014cited by this paper
• Generating Symmetry in the Asymmetric ATP-binding Cassette (ABC) Transporter Pdr5 from Saccharomyces cerevisiae*

  2014cited by this paper
• Phosphatidylinositol binding of Saccharomyces cerevisiae Pdr16p represents an essential feature of this lipid transfer protein to provide protection against azole antifungals

  2014cited by this paper
• Analysis of the Genome and Transcriptome of Cryptococcus neoformans var. grubii Reveals Complex RNA Expression and Microevolution Leading to Virulence Attenuation

  2014cited by this paper
• The Rbf1, Hfl1 and Dbp4 of Candida albicans regulate common as well as transcription factor-specific mitochondrial and other cell activities

  2014cited by this paper
• Altered sterol composition renders yeast thermotolerant

  2014cited by this paper
• Mapping the Cellular Response to Small Molecules Using Chemogenomic Fitness Signatures

  2014cited by this paper
• High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions.

  2014cited by this paper
• Activation of the Pleiotropic Drug Resistance Pathway Can Promote Mitochondrial DNA Retention by Fusion-Defective Mitochondria in Saccharomyces cerevisiae

  2014cited by this paper
• Mutations adjacent to the end of transmembrane helices 6 and 7 independently affect drug efflux capacity of yeast ABC transporter Pdr5p.

  2014cited by this paper
• Drug Resistance Is Conferred on the Model Yeast Saccharomyces cerevisiae by Expression of Full-Length Melanoma-Associated Human ATP-Binding Cassette Transporter ABCB5

  2014cited by this paper
• Epidemiology and risk factors for invasive candidiasis

  2014cited by this paper
• Activation of signaling pathways related to cell wall integrity and multidrug resistance by organic solvent in Saccharomyces cerevisiae

  2013cited by this paper
• Antifungal Azoles: Structural Insights into Undesired Tight Binding to Cholesterol-Metabolizing CYP46A1

  2013cited by this paper
• Genomewide screening for genes involved in biofilm formation and miconazole susceptibility in Saccharomyces cerevisiae.

  2013cited by this paper
• Heterologous expression of Candida albicans Pma1p in Saccharomyces cerevisiae.

  2013cited by this paper
• The ‘obligate diploid’ Candida albicans forms mating-competent haploids

  2013cited by this paper
• Mapping the functional yeast ABC transporter interactome

  2013cited by this paper
• Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans.

  2013cited by this paper
• Yeasts as a tool for heterologous gene expression.

  2012cited by this paper
• An Integrated Approach for Identification and Target Validation of Antifungal Compounds Active against Erg11p

  2012cited by this paper
• Potent Synergistic Effect of Doxycycline with Fluconazole against Candida albicans Is Mediated by Interference with Iron Homeostasis

  2012cited by this paper
• A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.

  2012cited by this paper
• Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a d‐octapeptide derivative inhibitor

  2012cited by this paper
• Antifungals: Drug Class, Mechanisms of Action, Pharmacokinetics/Pharmacodynamics, Drug-Drug Interactions, Toxicity, and Clinical Use

  2012cited by this paper
• Saccharomyces cerevisiae--a model to uncover molecular mechanisms for yeast biofilm biology.

  2012cited by this paper
• Comparative Lipidomics in Clinical Isolates of Candida albicans Reveal Crosstalk between Mitochondria, Cell Wall Integrity and Azole Resistance

  2012cited by this paper
• Constituents of Hondurian propolis with inhibitory effects on Saccharomyces cerevisiae multidrug resistance protein Pdr5p.

  2012cited by this paper
• Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants

  2012cited by this paper
• Identification and Characterization of Antifungal Compounds Using a Saccharomyces cerevisiae Reporter Bioassay

  2012cited by this paper
• Saccharomyces Genome Database: the genomics resource of budding yeast

  2011cited by this paper
• Yeast: An Experimental Organism for 21st Century Biology

  2011cited by this paper
• The Monoamine Oxidase A Inhibitor Clorgyline Is a Broad-Spectrum Inhibitor of Fungal ABC and MFS Transporter Efflux Pump Activities Which Reverses the Azole Resistance of Candida albicans and Candida glabrata Clinical Isolates

  2011cited by this paper
• Loss of Mitochondrial Functions Associated with Azole Resistance in Candida glabrata Results in Enhanced Virulence in Mice

  2011cited by this paper
• Mitochondria and Fungal Pathogenesis: Drug Tolerance, Virulence, and Potential for Antifungal Therapy

  2011cited by this paper
• Probing the role of point mutations in the cyp51A gene from Aspergillus fumigatus in the model yeast Saccharomyces cerevisiae.

  2011cited by this paper
• From Saccharomyces cerevisiae to Candida glabrata in a few easy steps: important adaptations for an opportunistic pathogen

  2011cited by this paper
• Use of a yeast-based membrane protein expression technology to overexpress drug resistance efflux pumps.

  2010cited by this paper
• Changes in the Proteome of Candida albicans in Response to Azole, Polyene, and Echinocandin Antifungal Agents

  2010cited by this paper
• Synthetic genetic array (SGA) analysis in Saccharomyces cerevisiae and Schizosaccharomyces pombe.

  2010cited by this paper
• A yeast-based genomic strategy highlights the cell protein networks altered by FTase inhibitor peptidomimetics

  2010cited by this paper
• Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity

  2010cited by this paper
• Genomic Plasticity of the Human Fungal Pathogen Candida albicans

  2010cited by this paper
• Barcode technology in yeast: application to pharmacogenomics.

  2010cited by this paper
• Heterologous Expression of Mutated Eburicol 14α-Demethylase (CYP51) Proteins of Mycosphaerella graminicola To Assess Effects on Azole Fungicide Sensitivity and Intrinsic Protein Function

  2010cited by this paper

• Understanding adaptation to fluconazole: comparative insights into tolerance and resistance in Saccharomyces cerevisiae and Candida albicans

  2025cites this paper
• Advanced Spectroscopic and Theoretical Study and Assessment of Antimycotic Potential in a Synergistic Composition of a 1,3,4-Thiadiazole Derivative and Amphotericin B

  2025cites this paper
• Unlocking the potential of experimental evolution to study drug resistance in pathogenic fungi

  2024cites this paper
• Combining Fluconazole with Benzo[a]phenoxazine Derivatives as a Promising Strategy Against Fluconazole-Resistant Candida Species

  2024cites this paper
• Exploring the Antifungal Activity of Various Natural Extracts in a Sustainable Saccharomyces cerevisiae Model Using Cell Viability, Spot Assay, and Turbidometric Microbial Assays

  2024cites this paper
• In Saccharomyces cerevisiae ρ0 Cells, UME6 Contributes to the Activation of ABC Transporter Genes and Pleiotropic Drug Resistance via RPD3 and PDR3

  2024cites this paper
• Transcriptional regulation of ergosterol biosynthesis genes in response to iron deficiency

  2022cites this paper
• yEvo: experimental evolution in high school classrooms selects for novel mutations that impact clotrimazole resistance in Saccharomyces cerevisiae

  2022cites this paper
• Study of the mechanism of ε-poly-l-lysine as an antifungal on Candida albicans and Saccharomyces cerevisiae.

  2022cites this paper
• yEvo: A modular eukaryotic genetics and evolution research experience for high school students

  2022cites this paper
• Modulation of yeast Erg1 expression and terbinafine susceptibility by iron bioavailability

  2022cites this paper
• Digoxin Derivatives Sensitize a Saccharomyces cerevisiae Mutant Strain to Fluconazole by Inhibiting Pdr5p

  2022cites this paper
• The Production of Metabolites by Saccharomyces Cerevisiae and its Application in Biotechnological Processes

  2021cites this paper
• Itraconazole resistance of Trichophyton rubrum mediated by the ABC transporter TruMDR2

  2021cites this paper
• Shared evolutionary footprints suggest mitochondrial oxidative damage underlies multiple complex I losses in fungi

  2021cites this paper
• yEvo: Experimental evolution in high school classrooms selects for novel mutations and epistatic interactions that impact clotrimazole resistance in S. cerevisiae

  2021cites this paper
• Investigating the Antifungal Mechanism of Action of Polygodial by Phenotypic Screening in Saccharomyces cerevisiae

  2021cites this paper
• MFS1, a Pleiotropic Transporter in Dermatophytes That Plays a Key Role in Their Intrinsic Resistance to Chloramphenicol and Fluconazole

  2021cites this paper
• Clotrimazole-Induced Oxidative Stress Triggers Novel Yeast Pkc1-Independent Cell Wall Integrity MAPK Pathway Circuitry

  2021cites this paper
• Sterol Composition Modulates the Response of Saccharomyces cerevisiae to Iron Deficiency

  2021cites this paper
• Yeast Double Transporter Gene Deletion Library for Identification of Xenobiotic Carriers in Low or High Throughput

  2021influential citation
• Tetraconazole-induced Programmed Cell Death in Schizosaccharomyces pombe

  2021cites this paper
• Living Bacterial Microneedles for Fungal Infection Treatment

  2020cites this paper
• Batzelladine D and norbatzelladine L purified from marine sponge Monanchora arbuscula induce the reversal of fluconazole.

  2020cites this paper
• β-Lapachone enhances the antifungal activity of fluconazole against a Pdr5p-mediated resistant Saccharomyces cerevisiae strain

  2020cites this paper
• Deletion of CDR1 reveals redox regulation of pleiotropic drug resistance in Candida glabrata.

  2019cites this paper